INHERENT GROUP, LP

Q2 2022 13F Holdings Report, Stock Holdings

Signature - Title
Danielle Schaefer - CHIEF FINANCIAL OFFICER
Location
New York, NY
Holdings as of
30 Jun 2022
Value $
$196,564,000
Num holdings
23
Filing time
15 Aug 2022, 18:08:43 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included OEC, OAK STR HEALTH INC, COOP, BRIDGEBIO PHARMA INC, and XP.
Previous filing
Q1 2022 - 16 May 2022
Next filing
Q3 2022 - 14 Nov 2022
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q2 compared to 2022 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
DANIELLE SCHAEFER CHIEF FINANCIAL OFFICER New York, New York 15 Aug 2022

Mr. Anthony Lynn Davis as a Principal of Inherent Group GP, LLC, the reporting manager's general partner, has investment discretion over the investment portfolios reported herein.

Other Included Managers (1):

Num Name Location File Number
1 INHERENT GROUP GP, LLC New York, NY 028-19279